Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Prevalence and predictors of aspirin/NSAID use among patients with Lynch syndrome (LS).
Authors
Sachi Singhal
Fox Chase Cancer Center, Philadelphia, PA
Sachi Singhal , Yana Chertok , Nadine Osorio , Juan Pablo Chavez , Emma D. Riggs , Mary Beryl Daly , Michael J. Hall
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Cancer Disparities
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 19)
DOI
10.1200/JCO.2024.42.3_suppl.19
Abstract #
19
Poster Bd #
B20
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
A pan-cancer analysis of microsatellite instability as a predictor of Lynch syndrome in Chinese population.
First Author: Pinzhu Huang
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Outcomes with immunotherapy between Lynch syndrome vs non-Lynch syndrome microsatellite instability-high colorectal cancer.
First Author: Cody Eslinger
Poster
2023 ASCO Annual Meeting
A comprehensive analysis of clinical characterization in 149 Chinese patients with Lynch syndrome.
First Author: Junqiong Lin
Poster
2023 ASCO Annual Meeting
Healthcare utilization among individuals diagnosed with Lynch syndrome through a universal germline genetic testing program.
First Author: Heather Hampel